急性髂股深静脉血栓形成深静脉支架置入后再干预的危险因素与分类
该回顾性单中心队列研究分析了2013至2017年因急性髂股深静脉血栓形成接受成功溶栓并支架置入的133例患者(143条肢体),发现33.6%的肢体需再干预,再干预与下腔静脉血栓、支架跨越腹股沟韧带及抗凝依从性差相关,且再干预增加血栓后综合征风险,闭塞前再干预成功率更高。
要点
- 再干预与下腔静脉血栓(RR 2.16)、支架跨越腹股沟韧带(RR 2.08)及抗凝不依从(RR 7.09)相关。
- 闭塞前再干预成功率为100%(23/23),闭塞后为36.4%(8/25),RR 32.31。
- 需再干预者任何血栓后综合征发生率更高(RR 2.28),闭塞前再干预可提高成功率。
核心结论
- 大部分患者因潜在可预防因素需再干预,抗凝依从性、血栓负荷和血流不畅是患者选择时重要危险因素。
- 再干预增加血栓后综合征风险,且在血管闭塞前进行再干预成功率更高。
研究设计与样本
- 回顾性单中心队列研究,纳入2013至2017年因急性髂股深静脉血栓形成接受成功溶栓的患者,共133例患者143条肢体。
主要发现
- 143条肢体中48条(33.6%)需再干预,其中25条表现为再闭塞(17.4%),再干预中位时间为45天。
- 再干预与下腔静脉血栓(RR 2.16;P < .01)、支架跨越腹股沟韧带(RR 2.08;P < .01)及抗凝不依从(RR 7.09;P < .01)相关。
- 再干预成功31条(64.6%):闭塞前治疗23/23(100%) vs 闭塞后治疗8/25(36.4%),RR 32.31;P < .01。
- 需再干预者任何血栓后综合征发生率更高(中位Villalta评分3[四分位距1-5] vs 1[四分位距1-4];RR 2.28;P = .029)。
- 无完全血管闭塞者(再干预组和对照组)任何血栓后综合征发生率更低(14.0% vs 42.9%;RR 3.06;P < .01),中重度血栓后综合征发生率也更低(3.0% vs 14.3%;RR 4.76;P = .046)。
关键数值与推荐
- 技术问题见于再干预病例的54.2% vs 无需再干预病例的6.3%(P < .01)。
- 血液学问题见于再干预病例的33.3% vs 无需再干预病例的1.1%(P < .01)。
- 血流相关问题见于再干预病例的43.8% vs 无需再干预病例的0%(P < .01)。
- 再干预病例中27.1%为多因素,与较低血管挽救率相关,但生存分析中二期通畅率无显著差异(RR 1.70;P = .429)。
临床怎么用
- 作者认为抗凝依从性、血栓负荷和血流不畅是患者选择时需考虑的重要危险因素。
- 作者指出再干预增加血栓后综合征风险,且在血管闭塞前进行再干预成功率更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute iliofemoral deep vein thrombosis (DVT) is associated with the development of post-thrombotic syndrome (PTS). Thrombolysis and deep venous stenting can restore vessel outflow and can reduce the incidence of PTS. However, for a proportion of patients, subsequent stenosis or reocclusion will necessitate further intervention. In the present study, we aimed to identify the risk factors, examine the outcomes (reintervention success and PTS), and develop a classification system for reintervention. METHODS: A retrospective single-center cohort study of patients who had undergone successful lysis for iliofemoral DVT from 2013 to 2017. The patients' records and imaging studies were examined for demographics, risk factors, extent of thrombus and vessel clearance, stenting, flow, reintervention, anticoagulation compliance, Villalta score, and secondary patency. From our findings, a system of classification for patients for whom procedures have failed was developed, constituting technical, hematologic, flow related, or multiple factors. RESULTS: Of 143 limbs (133 patients), 48 (33.6%) had required reintervention, of which 25 had presented with reocclusion (17.4%). The median time to reintervention was 45 days. The need for reintervention was associated with inferior vena cava thrombus (risk ratio [RR], 2.16; P < .01), stenting across the inguinal ligament (RR, 2.08; P < .01), and anticoagulation noncompliance (RR, 7.09; P < .01). Successful reintervention was achieved in 31 limbs (64.6%): 23 of 23 (100%) treated before occlusion vs 8 of 25 (36.4%) treated after occlusion (RR, 32.31; P < .01). A greater incidence of any PTS was observed for patients requiring reintervention (median Villalta score, 3 [interquartile range, 1-5]; vs 1 [interquartile range, 1-4]; RR, 2.28; P = .029). Cases without complete vessel occlusion (reintervention and control) had a lower rate of any PTS (14.0% vs 42.9%; RR, 3.06; P < .01) and moderate to severe PTS (3.0% vs 14.3%; RR, 4.76; P = .046) Technical issues were observed in 54.2% of reintervention cases and 6.3% of cases not requiring reintervention (P < .01). Hematologic issues were identified in 33.3% of reintervention cases and 1.1% of cases not requiring reintervention (P < .01). Flow-related issues were observed in 43.8% of the reintervention cases and no cases not requiring reintervention (P < .01). Of the reintervention cases, 27.1% were multifactorial and were associated with a lower rate of vessel salvage; however, this did not translate into a significant difference in secondary patency on survival analysis (RR, 1.70; P = .429). CONCLUSIONS: A large proportion of patients required reintervention because of potentially preventable factors. Anticoagulation compliance, thrombus burden, and poor flow are important risk factors to consider in patient selection. Reintervention increased the risk of PTS and was more often successful when achieved before vessel occlusion.
引用
- Pouncey AL, Kahn T, Morris RI, et al. Risk factors and classification of reintervention following deep venous stenting for acute iliofemoral deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 35358730. doi:10.1016/j.jvsv.2022.03.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。